Jetblue Airways Corp (JBLU) shows promising results

While Jetblue Airways Corp has underperformed by -7.88%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, JBLU fell by -23.73%, with highs and lows ranging from $8.31 to $3.34, whereas the simple moving average fell by -29.70% in the last 200 days.

On May 15, 2025, Raymond James Downgraded Jetblue Airways Corp (NASDAQ: JBLU) to Mkt Perform. A report published by Raymond James on April 07, 2025, Upgraded its rating to ‘Outperform’ for JBLU. Deutsche Bank also Downgraded JBLU shares as ‘Hold’, setting a target price of $7 on the company’s shares in a report dated March 04, 2025. BofA Securities January 17, 2025d its ‘Neutral’ rating to ‘Underperform’ for JBLU, as published in its report on January 17, 2025. Morgan Stanley’s report from December 11, 2024 suggests a price prediction of $8 for JBLU shares, giving the stock a ‘Equal-Weight’ rating. UBS also rated the stock as ‘Sell’.

Analysis of Jetblue Airways Corp (JBLU)

Further, the quarter-over-quarter decrease in sales is -3.12%, showing a negative trend in the upcoming months.

Jetblue Airways Corp’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -11.30% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.97, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and JBLU has an average volume of 27.95M. On a monthly basis, the volatility of the stock is set at 4.13%, whereas on a weekly basis, it is put at 4.52%, with a loss of -16.47% over the past seven days. Furthermore, long-term investors anticipate a median target price of $4.27, showing growth from the present price of $4.21, which can serve as yet another indication of whether JBLU is worth investing in or should be passed over.

How Do You Analyze Jetblue Airways Corp Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 19.96%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 78.27% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

JBLU shares are owned by institutional investors to the tune of 78.27% at present.

Hot this week

Investing in SolarBank Corporation (SUUN) might be an excellent idea, but the stock is currently overvalued/undervalued

While SolarBank Corporation has underperformed by -1.99%, investors are...

Can you now get a good deal on Sharps Technology Inc’s shares?

While Sharps Technology Inc has overperformed by 1.75%, investors...

Treasure Global Inc (TGL) deserves closer scrutiny

While Treasure Global Inc has overperformed by 0.81%, investors...

AEON Biopharma Inc (AEON) produces promising results

While AEON Biopharma Inc has underperformed by -0.29%, investors...

How did Volato Group Inc (SOAR) fare last session?

While Volato Group Inc has overperformed by 1.55%, investors...

Topics

Can you now get a good deal on Sharps Technology Inc’s shares?

While Sharps Technology Inc has overperformed by 1.75%, investors...

Treasure Global Inc (TGL) deserves closer scrutiny

While Treasure Global Inc has overperformed by 0.81%, investors...

AEON Biopharma Inc (AEON) produces promising results

While AEON Biopharma Inc has underperformed by -0.29%, investors...

How did Volato Group Inc (SOAR) fare last session?

While Volato Group Inc has overperformed by 1.55%, investors...

Is Oruka Therapeutics Inc (ORKA) a threat to investors?

While Oruka Therapeutics Inc has underperformed by -0.08%, investors...

Can you still get a good price for IO Biotech Inc (IOBT) Shares at this point?

Within its last year performance, IOBT rose by 61.96%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.